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ABSTRACT: The glmS riboswitch is unique among generegulating riboswitches and catalytic RNAs. This is because its
own metabolite, glucosamine-6-phosphate (GlcN6P), binds to
the riboswitch and catalytically participates in the RNA selfcleavage reaction, thereby providing a novel negative feedback
mechanism. Given that a number of pathogens harbor the
glmS riboswitch, artiﬁcial actuators of this potential RNA target
are of great interest. Structural/kinetic studies point to the 2amino and 6-phosphate ester functionalities in GlcN6P as
being crucial for this actuation. As a ﬁrst step toward developing artiﬁcial actuators, we have synthesized a series of nine GlcN6P
analogs bearing phosphatase-inert surrogates in place of the natural phosphate ester. Self-cleavage assays with the Bacillus cereus
glmS riboswitch give a broad SAR. Two analogs display signiﬁcant activity, namely, the 6-deoxy-6-phosphonomethyl analog (5)
and the 6-O-malonyl ether (13). Kinetic proﬁles show a 22-fold and a 27-fold higher catalytic eﬃciency, respectively, for these
analogs vs glucosamine (GlcN). Given their nonhydrolyzable phosphate surrogate functionalities, these analogs are arguably the
most robust artiﬁcial glmS riboswitch actuators yet reported. Interestingly, the malonyl ether (13, extra O atom) is much more
eﬀective than the simple malonate (17), and the “sterically true” phosphonate (5) is far superior to the chain-truncated (7) or
chain-extended (11) analogs, suggesting that positioning via Mg coordination is important for activity. Docking results are
consistent with this view. Indeed, the viability of the phosphonate and 6-O-malonyl ether mimics of GlcN6P points to a potential
new strategy for artiﬁcial actuation of the glmS riboswitch in a biological setting, wherein phosphatase-resistance is paramount.

R

cally unique as it is the only known riboswitch for which
catalytic activity provides the basis of genetic regulation, and it
is the only known ribozyme that depends upon a “coenzyme”
or actuator, namely its metabolite GlcN6P, for selfcleavage.11,12 The glmS riboswitch/ribozyme selectively binds
GlcN6P, thereby accelerating the cleavage reaction by at least 6
orders of magnitude.3,12 This results in the release of a large
downstream fragment, including the coding region of the
mRNA that is degraded by RNase J1.13 In the presence of
GlcN6P but not UDP-N-acetylglucosamine, the ﬁnal product of
this pathway, the intracellular concentration of the GlmS
enzyme, is decreased, but expression is not completely
inhibited.4
The glmS riboswitch self-cleavage mechanism most consistent with experimental evidence to date is illustrated in
Figure 2.12,14−20 Whereas early on it had been postulated that
G33 could serve as the general base needed for 2′-OH
deprotonation at the A1 position,17 discrepancies between the
pKa of the cleavage reaction and both the calculated21 and the
measured microscopic22 pKa of G33 called this into question. In

iboswitches are found in noncoding regions of mRNAs,
and gene expression is modulated when a metabolite
binds directly to the RNA. Many riboswitches, once liganded,
repress expression of associated or adjacent genes involved in
the synthesis of the metabolite, providing an eﬃcient feedback
mechanism of genetic control.1,2 The glmS riboswitch resides
upstream of the glmS gene in B. subtilis and in a number of
other Gram-positive bacteria.3 It is an essential gene that
encodes for the GlmS enzyme, glucosamine 6-phosphate
synthase, which uses fructose-6-phosphate (Fru6P) and
glutamine to generate glucosamine-6-phosphate (GlcN6P).4
This reaction is the ﬁrst committed step in the pathway that
produces UDP-N-acetylglucosamine, key for bacterial cell wall
biosynthesis.4,5 The glmS riboswitch is found in high proﬁle
bacterial targets, including B. anthracis, Clostridium diﬃcile, and
Staphylococcus aureus, motivating eﬀorts to develop artiﬁcial
actuators.6−8 Indeed, structure−activity relationship (SAR)
studies of other riboswitches and how they interact with their
cognate metabolites have enabled rational design of artiﬁcial
agonists and ultimately antibiotics.8,9
The glmS riboswitch consists of four paired regions P1−P4
that exhibit a high level of sequence conservation, particularly
within the catalytic core where nucleotide identities are >95%
conserved (Figure 1).3,10 The glmS riboswitch is mechanisti© 2014 American Chemical Society
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The picture that has emerged is one in which the 2-amino
group of GlcN6P serves as both a general base and a general
acid, a mechanistic postulate that is well precedented in both
related protein25,26 and nucleic acid chemistry.27,28 This
proposal aligns nicely with Raman diﬀerence crystallography
studies29 and computational simulations,30 indicating that upon
riboswitch binding, the pKa of the GlcN6P amino group is
lowered to align with the optimal reaction pKa.
Beyond this, speciﬁc sugar hydroxyl groups also are
advantageous for binding/catalysis,12,15−18,20,24,31 with the 4hydroxyl group serving as a hydrogen-bond donor. Interestingly, a carba-sugar analog of GlcN6P has been reported to
promote glmS ribozyme self-cleavage with activity similar to
that of the natural metabolite, suggesting that the ring oxygen is
not essential.31,32 Finally, the riboswitch selectively binds to the
α-anomer of GlcN6P, pointing to possible involvement of the
anomeric hydroxyl in binding and/or catalysis.33
In addition to the structural constraints articulated above,
available X-ray crystallographic structures suggest that the
phosphate ester functionality is important for positioning the
GlcN6P actuator in the riboswitch active site via chelation to
Mg2+. Given the susceptibility of phosphate esters to cleavage
by digestive phosphatases, it was a principal goal of this study to
develop riboswitch actuators that are phosphatase-inert. The
simplest design might be to replace the bridging phosphate
monoester oxygen with a carbon, to generate phosphonate
analogs.
There is currently great interest in naturally occurring
phosphonates, as antibiotics,34 including the widely used
fosfomycin,35,36 a PEP analog that inactivates UDP-GlcNAc3-enolpyruvyl transferase (MurA), a critical enzyme in bacterial
cell wall biosynthesis. More recently, fosmidomycin has shown
promise as a potential antituberculosis lead compound, as it
potently inhibits DXR in the committed step for the
nonmevalonate isoprenoid biosynthetic pathway.37 Indeed,
Metcalf and co-workers have dubbed this “an underexplored
family of secondary metabolites.”38
The Berkowitz group has a longstanding interest in the
synthesis of unnatural phosphonates39−45 and in their use to
probe active sites46 and glycoprotein receptor binding
pockets,47,48 for example. Therefore, we initially set about to
construct a set of phosphonate mimics of GlcN6P as potential
artiﬁcial actuators of the glmS riboswitch.

Figure 1. Secondary structure of the Bacillus cereus glmS riboswitch/
ribozyme. The highly conserved core sequence of the glmS ribozyme is
shown in red (P2.1 and P2.2), while requisite structural elements (P1
and P2) and peripheral structural elements (P3−P4) are also displayed
with nucleotide detail. The arrowhead denotes the site of self-cleavage.

■

RESULTS AND DISCUSSION
Design and Synthesis of GlcN6P Analogs. Synthetically,
the key strategy undertaken was to develop a synthetic route
into a viable glucosamine-6-O-triﬂate, for installation of various
phosphate surrogate functionalities. In earlier work, we had
established the utility of sugar triﬂate displacement with Cnucleophiles in general,49 and toward sugar phosphonates in
particular.42−46,50 However, prior to this work, triﬂates derived
from amino-sugars had not been synthesized or examined for
displacement with this chemistry. A signiﬁcant challenge was to
install an amino protecting group (PG) that would be amenable
to primary sugar triﬂate preparation. Initial forays into N-acetyl
protection met with little success at the triﬂate installation
stage. On the other hand, more strongly electron-withdrawing
N-sulfonyl PGs proved successful, with the (2′-trimethylsilyl)ethanesulfonyl (SES) PG being optimal.
The synthetic route begins with the glucal 1 and introduces
the 2-amino functionality via glycal iodo-sulfonamidination
(Figure 3). Then the amino group “rolls over” from the 1- to

Figure 2. Illustration of the dual general base/acid mechanism for
GlcN6P-promoted strand scission in the glmS ribozyme. GlcN6P is
proposed to promote 2′,3′-cyclic phosphodiester formation by
completing a circuit of proton transfer events that includes (indirect)
deprotonation of the nucleophilic 2′-OH of the A-1 riboside and
protonation of the 5′-O leaving group. Other active site bases that
have been implicated in proton transfer or H-bonding roles here
include the O2′ of A58, N1 of G33, N1 of G32, and O4 of U43.

fact, it has been demonstrated that glmS self-cleavage is
dependent upon the pKa of the amine functionality of GlcN6P
and other actuators,12 with a Bronsted β value of 0.7 having
been observed in a recent study, suggesting that the general
base role resides in the GlcN6P ligand itself.23 GlcN6P analogs
that lack the amine functionality do not support glmS selfcleavage; those with elevated amine pKa values support selfcleavage activity at elevated reaction pKa values,12 and those
that remove the N lone pair via quaternization or sequestration
through amide protection are also ineﬀective.24
2876
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13, was constructed by Rh(II)-mediated O−H insertion of the
carbenoid species derived from dibenzyl diazomalonate (Figure
5). The dicarboxylic acid derivative 17 and the monocarboxylic

Figure 3. Sulfonamido-glycosylation/N-rollover entry to SESprotected glucosamino-triﬂate 4 leading to GlcN6P phosphonate
analog 5; IDCP = iodonium di(sym-collidine) perchlorate.

the 2-position, via a presumed N-sulfonyl aziridine intermediate.51,52 With further protection of the nitrogen and removal of
6-O-silyl PG, the free alcohol 3 was prepared and stored in
large quantity. The reaction between 3 and triﬂic anhydride
under basic conditions gave the glucosamine 6-O-triﬂate 4
expeditiously (91% yield). Direct displacement with lithiomethyl dibenzyl phosphonate53 proceeded smoothly and was
followed by SES deprotection and subsequent catalytic
hydrogenation to aﬀord the phosphonate 5, the targeted
GlcN6P surrogate, for the ﬁrst time.
In addition, we set out to explore tether length in such
phosphonate-based analogs (Figure 4). SN2 substitution of the

Figure 5. Synthesis of GlcN6P analogs with mono- and biscarboxylate-based phosphate surrogates.

acid derivative 18, in turn, could be accessed from intermediate
14, which was eﬃciently formed in the reaction of triﬂate 4 and
lithiodibenzyl malonate.
The GlcN6P-like phosphoramide was next targeted as the
aza-analog of the parent phosphate monoester. The common
precursor triﬂate 4 was displaced by azide in 89% yield.
Cleavage of the N-sulfonyl linkage with nucleophilic ﬂuoride
and then Staudinger reduction conveniently produced compound 20. The primary amine was then reacted with dibenzyl
chlorophosphate to install the phosphoramide. Global
debenzylation gave phosphoramide analog 22 (Figure 6).

Figure 4. Triﬂate displacement route into the “truncated” and
“elongated” analogs of the parent GlcN6P-phosphonate mimic.

key intermediate triﬂate 4 by dibenzyl phosphite anion aﬀorded
compound 6 in 80% yield. Following the standard deprotection
method, “truncated” phosphonate 7 was synthesized. Triﬂate
displacement by a malonate anion followed by a decarboxylation/reduction sequence built the “elongated” alcohol 9.
However, the extended triﬂate was unstable even at low
temperature (−40 °C). Thus, an iodide intermediate was
instead employed. Displacement with a phosphite anion and
then sequential N-SES and global benzyl deprotection provided
compound 11 as an “elongated” phosphonate analog.
Motivated by recent studies on a malonate-based analog that
binds to a sugar phosphate-binding site in phosphomannose
isomerase,54 we next targeted three carboxylate-bearing
GlcN6P surrogates. One of these, namely the malonyl ether

Figure 6. Construction of the phosphoramide GlcN6P analog.

Because of the key role postulated for the 2-amino group in
catalysis, N-methylation was next explored.24 Thus, silyl ether 2
was methylated and deprotected with TBAF. Following triﬂate
displacement, deprotection of the SES amide and global
benzylation aﬀorded N-monomethylated phosphonate 27
(Figure 7). The SES-deprotected compound 25 could be
further methylated with methyl iodide, to yield the N,Ndimethyl analog 28, after deprotection.
2877

dx.doi.org/10.1021/cb500458f | ACS Chem. Biol. 2014, 9, 2875−2882

ACS Chemical Biology

Articles

Figure 7. Synthesis of the N-mono- and N,N-dimethylamino
derivatives of the parent phosphonate.

Self-Cleavage Assays with the glmS Riboswitch. The
Bacillus cereus glmS ribozyme was utilized in self-cleavage
kinetic assays performed in the presence of various synthesized
GlcN6P analogs. Nine analogs were tested for their ability to
support glmS self-cleavage (Figure 8). Seven of the nine analogs
contain an unmodiﬁed amine functionality. The remaining two
analogs combine the “sterically true” phosphonate ester with Nmethylated amino groups. Mono- or dimethylation of the
amine still retains the lone pair on nitrogen, which would, in
principle, still allow the amine to function as a general base/
acid.
Cleavage assays and data are presented in Figure 8 and Table
1, as well as in the SI. Of the nine analogs tested, ﬁve exhibited
signiﬁcant self-cleavage rates (kobs), namely, the sterically true
phosphonate (5) and its N-methyl (27) and N,N-dimethyl
(28) congeners, as well as the malonyl ether (13) and the
phosphoramide (22). While GlcN6P is the natural actuator/
ligand for the glmS riboswitch, the self-cleavage rate is diﬃcult
to measure accurately (see range given in Table 1), with
reported values for the kobs(GlcN6P)/kobs(GlcN) ratio ranging
from 37:112 to 143:1.23 Therefore, for experimental benchmarking, we have chosen to compare our results to the ligand
analog GlcN. The observed pseudo-ﬁrst-order rate constants
(kobs) for riboswitch cleavage with the artiﬁcial actuators at pH
7.3 are collected in the table.
As can be seen from the primary data (see SI), the other four
analogs, namely the chain-truncated phosphonate (7), the
chain-elongated phosphonate (11), the simple malonate (17),
and the monocarboxylate (18), show only very modest
induction of glmS riboswitch self-cleavage (Note: Owing to
limited quantities of material, compounds 11 and 18 were
tested at 1 mM concentrations, rather than the 10 mM
concentrations used for the other analogs).
Follow-up kinetic assays were conducted on the ﬁve most
active analogs, the sterically true phosphonate (5) and its Nmethyl (27) and N,N-dimethyl (28) congeners, as well as the
malonyl ether (13) and the phosphoramide (22). These
experiments were undertaken to estimate pseudo-second-order
rate constants (i.e., kcat/Km ) at subsaturating cofactor
concentrations, according to the approach of Fedor and
Viladoms.23 Pleasingly, the “sterically true” phosphonate analog
(5) and the 6-O-malonyl ether (13) exhibited the greatest
catalytic eﬃciency, 22-fold and 27-fold more reactive than
glucosamine, respectively (Table 1).

Figure 8. GlcN6P analog-actuated glmS ribozyme self-cleavage. Shown
are products of reactions incubated for varying times in the presence of
10 mM analog. Bands correspond to the ribozyme (open arrowhead)
and its 3′-cleavage product (ﬁlled arrowhead). Note: Data for the less
active analogs is in the SI.

Table 1. Kinetic Parameters for glmS Self-Cleaving
Ribozyme
kcat/Km
actuator

kobs (min−1)a

(mM−1min−1)b

RCEc

5
13
17
22
27
28
GlcN
GlcN6P

0.924 ± 0.10
1.01 ± 0.21
0.00579 ± 0.00015
0.101 ± 0.013
0.027 ± 0.011
0.0423 ± 0.010
0.174 ± 0.025
1.1−10012,23

0.394
0.488
0.0016
0.0101
0.0035
0.0100
0.0178
∼9823

22.1
27.4
0.0898
0.567
0.197
0.562
1.00
5510

a
10 mM actuator, pH 7.3, 25 °C; rates are ± standard deviation. b1.0−
0.01 mM actuator, pH 7.3, 25 °C. cRelative Catalytic Eﬃciency (RCE)
= kcat/Km relative to GlcN.

These results provide strong support for the notion that the
phosphate is critical to GlcN6P positioning in the riboswitch
“active site.” This is seen in the phosphonate series, in which
2878
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1,3-dicarboxylic acids indicates that pKa2 of the malonate analog
(17) is 5.3 and that of the malonyl ether (13) is 3.9 (SI: Figure
S2). Therefore, both of these bis-carboxylates are in their
dianionic forms under the conditions of the assay. Given this,
each analog was docked to the glmS riboswitch in dianionic
form. The results are striking (Figure 10). The malonyl ether

only the analog (5) possessing a single methylene (CH2) unit
in place of the bridging phosphate oxygen is eﬀective. Deletion
of this methylene (in 7) or insertion of an additional methylene
(in 11) all but abolishes this activity. In addition to this
apparent positioning constraint, a dianionic end group also
appears to be advantageous. This can be seen in the carboxylate
mimic series, wherein the monocarboxylate (18) is nearly
inactive.
Further modiﬁcations to the best phosphonate analog (5),
namely N-mono- and dimethylation, did not lead to improved
activity. The measured pKa2 for the monomethylated analog
(27) is 8.2, whereas the pKa2 for the dimethylated analog (28)
is 7.8. So, based upon acid−base chemistry considerations
alone, one might predict that the latter analog would be the
superior analog. Indeed, while 28 does outperform 27, given
that 5 displays a nearly 40-fold better kcat/Km, relative to both
27 and 28, it would appear that in this series, deleterious sterics
are the dominant factor.
We set about to examine the binding of the most promising
analogs more closely via molecular docking. There are currently
six published X-ray crystal structures of the glmS riboswitch
precleavage complex with GlcN6P bound, four from
Thermoanaerobacter tengcongensis (2Z74, 2Z75, 3B4B,
3B4C)15,17,18 and two from Bacillus anthracis [3G8T (G33A,
2NZ4 (2′OMe-A-1))].16,20 The latter structure was chosen as
the B. anthracis riboswitch displays 98% identity with the B.
cereus riboswitch employed in the cleavage assays in this work.
As can be seen in Figure 9, deletion of the bound GlcN6P,

Figure 10. Overlay of docked structures of malonate and malonyl
ether analogs in the active site. Green represents malonate analog;
magenta represents malonyl ether analog. The carboxylates of the
malonyl ether bind tightly with two Mg2+ ions with the amino group
poised to protonate the leaving oxygen atom. In the malonate analog,
coordination to two Mg2+ ions is also predicted. However, for this
analog, the amino group docks near the A42−U43 phosphodiester,
instead of the scissile A-1-G1 phosphodiester, consistent with the weak
actuator activity of compound 17.

analog is well positioned in the active site. However, in contrast
to the native GlcN6P ligand or its phosphonate analog 5, the biscarboxylate moiety appears to permit coordination to two
magnesium ions in the active site (Figure 10). A similar bischelation motif is observed for the docked malonate (17) as
well. However, for the latter ligand, docking suggests that the 2amino group is improperly positioned for catalysis, interacting
with the A42−U43 phosphodiester bond rather than with the
susceptible phosphodiester linkage between A-1 and G1.
Structural biology studies (e.g., cocrystallization) may be able
to shed further light on this molecular-docking-based model for
malonyl ether/malonate binding to the riboswitch in the future
(Note: In response to a reviewer suggestion, a preliminary
screen of self-cleavage rate vs Mg2+ concentration was carried
out with the P1−P4 construct of the glmS riboswitch and
indicates that for both GlcN and GlcN6P, across a range of 1−
100 mM Mg2+, reaction rates are fairly constant, whereas the
rate of the reaction with the malonyl ether (13) from 1 to 10
mM Mg2+ increases 4.5-fold and then remains fairly constant
from 10 to 100 mM).
In examining the literature on malonate-type surrogates for
biological phosphates, one certainly ﬁnds cases in which simple
malonates make for good analogs, in sharp contrast with our
ﬁndings here, e.g., the aforementioned malonate analog of M6P
(phosphomannose isomerase).54 Indeed, in one head-to-head
case carefully examined by Frost and co-workers, the malonate
substrate analog displayed an order of magnitude superior
activity to its malonyl ether counterpart in the inhibition of 3dehydroquinate synthase.55 Moreover, we previously saw a

Figure 9. Projected orientation of phosphonate analog 5 when bound
to glmS riboswitch; docked to glmS structure 2NZ4 (Bacillus
anthracis).

followed by molecular docking (Autodock 4-see SI for details)
of the dianionic form of phosphonate 5 supports a model in
which Mg2+-coordination projects the 2-amino group appropriately for its putative general acid/base function in the
cleavage reaction.
To better assess ligand charge, titrations for the most
interesting analogs were carried out, and the results are
tabulated in the SI. Of potential signiﬁcance, the second pKa of
phosphonate analog 5 was determined to be ∼7.4 from titration
curves (SI: Figure S2A). Therefore, under the cleavage assay
conditions (pH 7.3), only ∼50% of the phosphonate moiety is
dianionic, although modeling suggests that this form is required
for optimal binding through magnesium ion chelation.
Therefore, the diminished activity of 5 relative to the native
GlcN6P ligand (pKa2 ∼ 6.2)12 and to the malonyl ether (13)
may be at least in part due to the elevated second pKa of
phosphonate.
Interestingly, the simple malonate analog, 17, is ∼300-fold
less active than the malonyl ether analog 13. Titration of these
2879
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similar preference for simple malonates over malonyl ether
mimics of M6P in binding to the M6P-insulin-like growth
factor II receptor.48
On the other hand, perhaps the best case of a particularly
active malonyl ether phosphate mimic described heretofore was
in a classic study by Sikorski et al. at Monsanto toward the
development of novel EPSP synthase inhibitors.56 However,
this may be the ﬁrst indication of the potential advantage of a
malonyl ether in bis-carboxylate positioning for metal ion
coordination, indeed possibly for bis-Mg coordination.
Taken together, the results of this study suggest that both the
malonyl ether (13) and the sterically true phosphonate (5)
mimics of GlcN6P are promising starting points for the
development of phosphatase-resistant artiﬁcial actuators for the
glmS riboswitch as is critical for in vivo application. We note
that these actuators are only ∼1/7 as active as the natural ligand
GlcN6P, and therefore there is potential for improvement.
Future studies will be guided by the observations reported
herein and will build upon these two promising lead platforms.

■

AUTHOR INFORMATION

Corresponding Authors

*E-mail: dberkowitz1@unl.edu.
*E-mail: jksoukup@creighton.edu.
Notes

The authors declare no competing ﬁnancial interest.

■

ACKNOWLEDGMENTS

■

REFERENCES

The authors wish to thank the National Institutes of Health
(GM-R15M083641) for support of this collaboration. The
Soukup laboratory thanks M. and K. Delaney for their generous
donation to riboswitch research. Additional support to J.K.S.
and A.S. came from grants from the National Center for
Research Resources (5P20RR016469) and the National
Institute for General Medical Science (5P20GM103427), to
L.H. from the Dr. R.M. and T.K. Ferlic Summer Research
Scholarship Program, to A.S. as a Goldwater Scholar, and to
J.K.S. and D.R. from the Clare Boothe Luce Women in Science
Program, funded by the Luce Foundation. This research was
facilitated by the IR/D (Individual Research and Development)
program associated with D.B.B.’s appointment at the NSF. The
authors thank the National Institutes of Health (SIG-1-510-RR06307)/NSF (CHE-0091975, MRI0079750) (UN NMR) and
National Institutes of Health (RR016544) (UN facilities).

METHODS

Synthesis of GlcN6P Analogs. The construction of the
phosphonate analogs exploited the triﬂate displacement chemistry
previously reported53,57 where possible. A detailed description of the
synthesis of all nine analogs and spectral data for each intermediate can
be found in the Supporting Information.
Preparation of RNA. Templates for transcription were prepared
by primer extension and PCR ampliﬁcation using synthetic DNA
corresponding to ribozyme sequence. Ribozymes were prepared by in
vitro transcription using T7 RNA polymerase and 32P-labeled by
incorporation of [α-32P]-UTP. Transcription products were separated
by denaturing 10% polyacrylamide gel electrophoresis (PAGE), and
ribozymes were eluted in solution containing 50 mM HEPES (pH 7.3
at 22 °C) and 200 mM NaCl, precipitated with ethanol, and
redissolved in water.12
Self-Cleavage Assay. Ribozyme reactions were performed as
previously described.12,23 Brieﬂy, reactions contained a ligand analog as
indicated and were performed under standard conditions consisting of
incubation at 22 °C in solution containing 50 mM HEPES pH 7.3. A
saturating concentration of MgCl2 was used in order to avoid a slow
folding step and to allow for the formation of native glmS RNA
structure.20,58 The [α-32P]-UTP-labeled glmS ribozyme (<250 nM)
was prefolded in 50 mM HEPES pH 7.5, 0.1 mM EDTA, and 50 mM
MgCl2 at 22 °C. Reactions were started by adding coenzyme at varying
concentrations (10 mM−10 μM ﬁnal concentration) in 50 mM
HEPES pH 7.3 buﬀer. Reactions were terminated by the addition of a
gel loading dye containing 10 M urea, 50 mM EDTA, 0.1%
bromophenol blue, and 0.1% xylene cyanol. Products were separated
by denaturing 10% PAGE and analyzed using a PhosphorImager and
IMAGEQUANT software (Molecular Dynamics). kobs values for selfcleavage were derived by plotting the natural logarithm of the fraction
of uncleaved ribozyme versus time and establishing the negative slope
of the resulting line. Stated values represent the average of at least
three replicate assays. First order cleavage rate constants were obtained
at diﬀerent concentrations of coenzyme in the linear range of a
Michaelis−Menten plot (ligand concentration ∼20% of apparent Km
value) and were ﬁt by linear regression to obtain apparent secondorder rate constants kcat/Km.23
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